Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Aerovent

Base Information Edit
  • Chemical Name:Aerovent
  • CAS No.:141197-26-4
  • Molecular Formula:C20H30 N O3
  • Molecular Weight:332.46
  • Hs Code.:
  • UNII:GR88G0I6UL
  • DSSTox Substance ID:DTXSID301107468
  • Nikkaji Number:J293.340C,J294.567C,J389.214J,J389.227A
  • NCI Thesaurus Code:C61794
  • RXCUI:7213
  • Pharos Ligand ID:9X69BB6AF6LC
  • ChEMBL ID:CHEMBL1398588
  • Mol file:141197-26-4.mol
Aerovent

Synonyms:(endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane;Atrovent;Ipratropium;Ipratropium Bromide;Ipratropium Bromide Anhydrous;Ipratropium Bromide Monohydrate;Ipratropium Bromide, (endo,anti)-Isomer;Ipratropium Bromide, (exo,syn)-Isomer;Ipratropium Bromide, endo-Isomer;Itrop;N Isopropylatropine;N-Isopropylatropine;Sch 1000;Sch 1178;Sch-1000;Sch-1178;Sch1000;Sch1178

Suppliers and Price of Aerovent
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
Total 1 raw suppliers
Chemical Property of Aerovent Edit
Chemical Property:
  • XLogP3:2.6
  • Hydrogen Bond Donor Count:1
  • Hydrogen Bond Acceptor Count:3
  • Rotatable Bond Count:6
  • Exact Mass:332.22256882
  • Heavy Atom Count:24
  • Complexity:430
Purity/Quality:

99%min *data from raw suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Drug Classes:Anticholinergic Agents
  • Canonical SMILES:CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C
  • Isomeric SMILES:CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)[C@@H](CO)C3=CC=CC=C3)C
  • Recent ClinicalTrials:Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
  • Recent EU Clinical Trials:A phase II, randomised, double blind, placebo controlled, six way crossover study to assess the bronchodilator effect of RPL554 administered on top of salbutamol and ipratropium in patients with COPD
Post RFQ for Price